Skip to main content
Clinical Trials/JPRN-jRCT1040220088
JPRN-jRCT1040220088
Not yet recruiting
未知

A cross-sectional observational study to identify the current status of shared decision making and factors influencing decision making of drug treatment among gynecological cancer patients and health care providers

Kitano Hiromi0 sites590 target enrollmentNovember 4, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kitano Hiromi
Enrollment
590
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 4, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Kitano Hiromi

Eligibility Criteria

Inclusion Criteria

  • \- Agreed web questionnaire survey.
  • \- 18 year and older.
  • \- Live in Japan.
  • \- Received chemotherapy for uterine cancer, ovarian cancer, or fallopian tube cancer.
  • \- Agreed web questionnaire survey.
  • \- Doctors, nurses, or pharmacists who are engaged in drug treatment for gynecological cancer.

Exclusion Criteria

  • \- Have families engaged in pharmatheutical/survey/marketing company or health care.
  • \- Have double cancer.
  • \- Doctors with less than 5 years of experience as a doctor (including training period).
  • \- Nurses and pharmacists with less than 1 year of experience.

Outcomes

Primary Outcomes

Not specified

Similar Trials